Acrivon Therapeutics, Inc. SEC filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | Acrivon Therapeutics, Inc. | 2026-05-13 | 0001193125-26-221634 |
| 10-K | Acrivon Therapeutics, Inc. | 2026-03-19 | 0001193125-26-115123 |
| 10-Q | Acrivon Therapeutics, Inc. | 2025-11-13 | 0001193125-25-280215 |
| 10-Q | Acrivon Therapeutics, Inc. | 2025-08-13 | 0000950170-25-108054 |